1. Home
  2. NNNN vs QUAD Comparison

NNNN vs QUAD Comparison

Compare NNNN & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • QUAD
  • Stock Information
  • Founded
  • NNNN 2021
  • QUAD 1971
  • Country
  • NNNN Germany
  • QUAD United States
  • Employees
  • NNNN N/A
  • QUAD N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • QUAD Publishing
  • Sector
  • NNNN Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • NNNN Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • NNNN 267.7M
  • QUAD 261.9M
  • IPO Year
  • NNNN 2025
  • QUAD 2010
  • Fundamental
  • Price
  • NNNN $6.43
  • QUAD $5.80
  • Analyst Decision
  • NNNN
  • QUAD Strong Buy
  • Analyst Count
  • NNNN 0
  • QUAD 2
  • Target Price
  • NNNN N/A
  • QUAD $9.45
  • AVG Volume (30 Days)
  • NNNN 28.8K
  • QUAD 361.3K
  • Earning Date
  • NNNN 01-01-0001
  • QUAD 04-29-2025
  • Dividend Yield
  • NNNN N/A
  • QUAD 5.16%
  • EPS Growth
  • NNNN N/A
  • QUAD N/A
  • EPS
  • NNNN 0.06
  • QUAD N/A
  • Revenue
  • NNNN $8,185,146.00
  • QUAD $2,646,800,000.00
  • Revenue This Year
  • NNNN N/A
  • QUAD N/A
  • Revenue Next Year
  • NNNN N/A
  • QUAD N/A
  • P/E Ratio
  • NNNN $118.17
  • QUAD N/A
  • Revenue Growth
  • NNNN 21.95
  • QUAD N/A
  • 52 Week Low
  • NNNN $5.18
  • QUAD $4.06
  • 52 Week High
  • NNNN $7.82
  • QUAD $9.13
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • QUAD 61.37
  • Support Level
  • NNNN N/A
  • QUAD $4.50
  • Resistance Level
  • NNNN N/A
  • QUAD $5.51
  • Average True Range (ATR)
  • NNNN 0.00
  • QUAD 0.31
  • MACD
  • NNNN 0.00
  • QUAD 0.11
  • Stochastic Oscillator
  • NNNN 0.00
  • QUAD 86.96

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

Share on Social Networks: